Athelas
About:
Athelas develops technology to monitor chronically ill patients in their homes.
Website: https://athelas.com/
Twitter/X: athelasdevice
Top Investors: Y Combinator, General Catalyst, Sequoia Capital, Elad Gil, Tribe Capital
Description:
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
Total Funding Amount:
$150M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Mountain View, California, United States
Founded Date:
2016-06-01
Contact Email:
contact(AT)athelas.com
Founders:
Deepika Bodapati, Tanay Tandon
Number of Employees:
101-250
Last Funding Date:
2022-01-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai